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a  b  s  t  r  a  c  t
Objectives:  To preliminarily  assess  the  effects  of  acupuncture  on  prehypertension  and  stage  I hypertension,
and  to provide  data  for further  research.
Design:  A randomized,  controlled,  assessor-blinded  study  with  an  8-week  intervention  period  and  a  4-
week follow-up.
Interventions:  Participants  were  patients  with  systolic  blood  pressure  (SBP)  of  120–159  mmHg  or  dias-
tolic  blood  pressure  (DBP)  of  80–99  mmHg.Thirty  participants  were  allocated  to  acupuncture  group  or
untreated  control  group  at  a 1:1  ratio.  The  acupuncture  group  received  standard  acupuncture  twice
weekly  for 8 weeks,  and was  followed-up  for 4 weeks  after  treatment;  the  control  group  did  not  receive
any  type  of  anti-hypertensive  treatment  for 12 weeks.
Main  outcome  measures:  Primary  outcome  measure  was SBP  and  DBP  at post-treatment.  The  secondary
outcomes  were SBP and DBP  at follow-up;  Euro  Quality  of  life  (EQ-5D),  heart  rate  variability  (HRV),  body
mass  index  (BMI),  and  blood  lipid proﬁle.
Results:  DBP  (−5.7 mmHg;  P = 0.025),  but  not  SBP  (−6.0  mmHg;  P = 0.123),  was signiﬁcantly  different
between  groups  at post-treatment.  Both  DBP  (−7.8  mmHg;  P = 0.004)  and SBP  (−8.6 mmHg;  P = 0.031)
were  signiﬁcantly  different  at follow-up.  Among  the  HRV  indices,  only  high  frequency  power  was  signif-
icantly  different  between  groups  at weeks  4  and  8 (P =  0.047  and  P = 0.030,  respectively).  There  were  no
differences  between  groups  in  EQ-5D,  BMI  or lipid proﬁle.
Conclusion:  The  results  of this  study  show  that  acupuncture  might  lower  blood  pressure  in  prehyper-
tension  and  stage  I  hypertension,  and  further  RCT  need  97 participants  in  each  group.  The effect  of
acupuncture  on prehypertension  and  mild  hypertension  should  be conﬁrmed  in larger  studies.
Trial registration:  KCT0000496.
d  by ©  2015  Z.  Publishe
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public health issue.1 In South Korea, the prevalence of hyperten-
sion is 29.0%.2 Globally, 51% deaths from cerebrovascular disease
and 45% deaths from ischemic heart disease are attributable to high
blood pressure (BP). 3 Hypertension, alongside heart disease, is one
of the top ten causes of direct health expenditures.4 In South Korea,
hypertension ranks ﬁrst in healthcare costs, and fourth among all
chronic diseases in quality of life.2,5
The Seventh Report of the Joint National Committee on Pre-
vention, Detection, Evaluation, and Treatment of High Blood
Pressure has deﬁned prehypertension as a systolic BP (SBP) of
120–139 mmHg  or a diastolic BP (DBP) of 80–89 mmHg.6 Research
indicates that prehypertension is an independent risk factor for
cardiovascular events that recommends anti-hypertensive man-
agement for patients with prehypertension.7 Prehypertension
alongside mild hypertension are recommended intensive lifestyle
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anagement rather than anti-hypertensive drugs for their initial
P lowering.8 Furthermore, the beneﬁts of anti-hypertensive drugs
or mild hypertension is not clear,9 and medication is accompanied
y unwanted side effects. Such situation and the difﬁculty to adopt
nd maintain lifestyle changes, have highlighted the limitations of
rugs in treating prehypertension and stage I hypertension.
Acupuncture is a form of traditional Chinese medicine that
as been used in Eastern countries to treat a number of diseases,
ncluding those related to the cardiovascular system,10 such as
ypertension.11 Although several well-designed large scale studies
ave investigated the effects of acupuncture on hypertension,12–14
et there are few studies to determine the effects of acupuncture
n prehypertension and mild hypertension. In addition, recent sys-
ematic review studies pointed out that due to low-quality clinical
ethodology and heterogeneity, it is hard to draw a conclusion on
cupuncture and hypertension.15
Therefore, we designed a randomized control study to pre-
iminarily assess the effects of acupuncture in the patients with
rehypertension and stage I hypertension. If the study feasibility
as acceptable, we would calculate the appropriate sample size
or a further larger-scale trial. Our ﬁndings will provide scientiﬁc
vidence to acupuncture studies on early stage hypertension, and
ould be useful for studies whose participants are un-medicated.
. Materials and methods
.1. Design
This was an assessor-blinded, parallel 2-armed, randomized
reliminary study. The two arms were acupuncture group versus
ntreated control group. Participants had been recruited and were
llocated one of the groups at a 1:1 ratio. Participants in the
cupuncture group had received standardized acupuncture treat-
ent 20 min  a session, twice weekly for 8 weeks, and followed
p 4 weeks after treatment completion; and participants in con-
rol group did not receive any antihypertensive related treatment
uring the study.
The study protocol was approved by the Institutional Review
oard at Dunsan Oriental Hospital, Deajeon University, South
orea. All participants received information about the study, signed
n informed consent sheet, and kept a duplicate of the signed
nformed consent sheet. If a participant initiated anti-hypertensive
reatment due to hypertension or hypertension-related symptoms,
he participant was immediately withdrawn from the study. After
tudy completion, the control group was offered acupuncture treat-
ent.
.2. Patients
Participants were eligible if they were aged 20–65 years, and had
ypertension with SBP 120–159 mmHg  or DBP 80–99 mmHg. We
xcluded participants with SBP > 160 mmHg  or DBP > 100 mmHg;
nd those who had had acupuncture or any antihypertensive-
elated treatment in the previous six months. Other exclusion
riteria were secondary hypertension; diabetes; a history of cere-
rovascular or cardiovascular disease; kidney, liver, thyroid gland
r hemorrhagic diseases; a history of active tuberculosis or other
nfectious diseases; vicious tumors; and pregnancy, lactation or
regnancy planning.
.3. Randomization and blindingA blinded statistician generated the random allocation sequence
sing SAS® 9.3 (SAS Institute Inc., Cary, NC, USA). Group allocation
as sealed in opaque envelopes and the envelopes were given to
ne of the researchers. To minimize selection bias, the researcher15) 658–665 659
opened the envelopes sequentially in front of the participants only
after they were included in the study, and informed them of the
allocation immediately. It was impossible to blind the participants
to group allocation, because participants in the control group did
not receive any treatment, but the assessors and the statistician
were blinded.
2.4. Intervention
Participants in the acupuncture group were treated with stan-
dardized acupuncture. We  used disposable stainless steel needles
(diameter: 0.20 mm,  length: 30 mm;  DongBang Acupuncture, Inc.,
Seoul, South Korea). In each session, participants were given de
qi sensation via manipulation right after inserting needle into the
skin, plus 20 min  of needle-retaining time. Four experts made con-
sensus on acupuncture points as bilateral ST36, PC6, LR3, SP4, LI11,
based on literatures,16,17 and theory of Oriental Medicine (Fig. 1).
Participants in the control group maintained their previous
lifestyle, and were not provided any anti-hypertensive treatment
during the study period. They were asked to visit once every two
weeks for BP monitoring.
Moreover, standard operation procedure was  provided for con-
sistency of procedure, and routine monitoring was  undertaken to
check out data management and the quality of study.
2.5. Outcome measures
The primary outcomes were mean differences of SBP and DBP
changes from baseline to post-treatment between acupuncture
group and control group. The secondary outcomes were (1) mean
differences of SBP and DBP changes between groups from baseline
to follow-up; (2) the differences of EuroQoL-5 dimension question-
naire (EQ-5D), heart rate variability (HRV) and body mass index
(BMI) between acupuncture group and control group at 4 and 8
weeks and at follow-up; and (3) fasting blood lipid proﬁle between
groups at 8 weeks and follow-up. We  also noted the mean differ-
ences of SBP and DBP within each of the two groups.
BP measurements were conducted at every visit for both groups;
the data were obtained before acupuncture treatment for the treat-
ment group. We  used automatic BP monitor (FT-500, Jawon Medical
Co., South Korea). At screening, BP levels were measured 3 times
at both left and right arms in 5-min intervals in sitting position,
the mean BPs of the higher BP’s arm was chosen for consistent BP
measurements. At all visits, BP levels took the mean BPs of 3 times
measurement.
EQ-5D is a preference-based tool to assess general health sta-
tus across ﬁve dimensions (mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression). 18 We used a Korean
version of the EQ-5D that has been validated in the Korean
population.19,20 The questionnaire scores referred to the South
Korean population-based preference weights for EQ-5D, each
answer ranging from 0 to 1. The higher the total score, the better
the quality of life.21
HRV was analyzed using Canopy® (CANPY9, IEMBIO Co.,
Ltd., South Korea). Canopy converts parameters of frequency
domain of HRV to natural logarithms from the decimal value.
Four frequency domain variables were studied: total power (TP:
0.01–0.40 Hz), high frequency power (HF: 0.15–0.40 Hz), low fre-
quency power (LF: 0.04–0.15 Hz), and very low frequency power
(VLF: 0.01–0.04 Hz). HF reﬂects the parasympathetic activity, VLF
reﬂects the sympathetic activity, LF represents both the sympa-
thetic and parasympathetic tone of the heart, and TP represents
the total power that generally represents overall autonomic activ-
ity. An increase of each index represents an increase of autonomic
activity.22 We  also tested the fasting blood lipid proﬁle and BMI.
Based on recent standards, the following cutoff values were used to






















lFig. 1. Acupuncture points selected for the hypertens
etermine the desirable levels of serum lipids: serum total choles-
erol below 200 mg/dL, high-density lipoprotein (HDL) cholesterol
bove 40 mg/dL, low-density lipoprotein (LDL) cholesterol below
00 mg/dL, and the normal BMI  ranges from 18.5 to 24.9.23
.6. Data analysis
SAS® 9.3 was used to analyze data based on the intent-to-treat
rinciple. Two-tailed test was used with a signiﬁcance level of 5%.
ecause there was no previous study on the effect of acupuncture
n prehypertension and stage I hypertension, we used a sample size
f 12 per group, based on previous studies,24,25 and considered a
0% dropout rate. Thus, we aimed to recruit 15 participants per
roup.
Differences between patients’ characteristics at baseline were
xpressed as descriptive statistics. Analysis of covariance was  con-
ucted with baseline scores as covariates and groups as factors
or between-group comparisons. To evaluate within-group dif-
erences, we used paired t-test or Wilcoxon signed-rank test. To
ope with missing data, we used last observation carried forward
ethod, with consideration that hypertension is a chronic disease
nd BP is relatively constant over time. The effect size was  calcu-
ated by using the mean difference and standard deviation (SD) of
P between groups after acupuncture treatment, in order to calcu-
ate the appropriate sample size for further research.eatment. (A) LI11; (B) SP4; (C) PC6; (D) ST36 and LR3.
3. Results
The study was  carried out from June 2012 to June 2013 at Dunsan
Oriental Hospital, Daejeon University, South Korea. Of the 69 poten-
tial participants contacted, 39 were excluded because they did not
meet the inclusion criteria (n = 33) or refused to participate (n = 6).
Fifteen participants were allocated to the acupuncture group, but
two dropped out during the treatment period; another 15 partic-
ipants were allocated to the control group, but two dropped out
during the study period. During follow-up, there were two  dropouts
from the acupuncture group and one from the control group. 86.7%
of both group participants ﬁnished the study period (Fig. 2).
3.1. Demographic data
The characteristics of the participants are summarized in
Table 1. There was no difference between the two  groups in terms
of age, sex, BP, HRV, BMI, EQ-5D and the number of participation
in each stage. HDL and total cholesterol were similar, but LDL  was
signiﬁcantly higher in the acupuncture group than in the control
group. However, since we  used randomized allocation, this differ-
ence might be caused by chance (Table 1).3.2. Primary outcome
There was a signiﬁcant difference in DBP (−5.7 mmHg; 95%
CI: −10.7, −0.8; P = 0.025) but a negligible difference in SBP
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Fig. 2. Flow diagram
Table 1






Age, years 49.4 ± 8.4 53.4 ± 8.2 0.198
Males, N (%) 3 (20.0)a 4 (26.7)a 1.000
BP,  mmHg
SBP 137.1 ± 10.0 138.5 ± 10.9 0.708
DBP 86.4 ± 6.5 85.19 ± 8.1 0.662
HRV
TP 5.9 ± 0.7 6.0 ± 0.7 0.637
VLF 5.1 ± 0.9 5.1 ± 0.7 0.764
LF 4.4 ± 0.8 4.5 ± 1.2 0.786
HF 4.6 ± 0.8 4.5 ± 1.1 0.721
Blood lipid proﬁle, mg/dl
HDL 50.5 ± 10.8 50.2 ± 12.8 0.939
LDL 125.6 ± 16.9 105.9 ± 19.1 0.006
Total cholesterol 198.5 ± 20.9 183.7 ± 27.7 0.109
BMI, kg/m2 23.5 ± 3.1 24.5 ± 3.4 0.435




a For “males” value, it is numbers (percentage), other values are the mean ± SD.
b P-value of comparison between groups. of the study.
(−6.0 mmHg; 95% CI: −13.7, 1.7; P = 0.123) change from baseline
to post-treatment between acupuncture group and control group.
In the acupuncture group, there was a signiﬁcant decrease in
SBP (−6.5 mmHg; P = 0.042) and DBP (-4.9 mmHg;  P = 0.006) from
baseline to post-treatment. In the control group, the changes in
SBP (−1.3 mmHg; P = 0.208) and DBP (1.2 mmHg; P = 0.934) were
not statistically signiﬁcant (Table 2).
Secondary outcome
4. Blood pressure
There were signiﬁcant differences in SBP (−8.6 mmHg; 95% CI:
−16.3, −0.8; P = 0.031) and DBP (−7.8 mmHg; 95% CI: −12.8, −2.8;
P = 0.004) at follow-up between acupuncture group and control
group. In the acupuncture group, there was a signiﬁcant decrease in
DBP (−4.6 mmHg; P = 0.002) but not in SBP (−5.0 mmHg; P = 0.135).
In the control group, neither DBP nor SBP were signiﬁcantly
changed (Table 2, Fig. 3).
To better understand the duration of the treatment interven-
tion, we  analyzed the differences at week 4. There was a signiﬁcant
difference in SBP (−7.8 mmHg; 95% CI: −14.6, −0.9; P = 0.027) and
DBP (−7.5 mmHg; 95% CI: −12.8, −2.2; P = 0.007) between the
two groups. In the acupuncture group, there was  a signiﬁcant
662 Y. Liu et al. / 23 (2015) 658–665
Table 2
Changes in BP from baseline to week 4, week 8 and follow-up.
Acupuncture (n = 15) Control (n = 15) Acupuncture vs. control
BPa Pc BPa Pc BPb Pd
Baseline SBP 137.1 ± 10.0 – 138.5 ± 10.9 – – –
DBP  86.4 ± 6.5 – 85.19 ± 8.1 – – –
Changes in week 4 SBP −7.1 ± 11.1 0.027* −0.1 ± 9.7 0.963 −7.8 0.027*
DBP −7.5 ± 6.6 0.001*** 0.6 ± 8.7 0.796 −7.5 0.007**
Changes in week 8 SBP −6.5 ± 11.4 0.042** −1.3 ± 11.5 0.208 −6.0 0.123
DBP  −4.9 ± 5.2 0.006** 1.2 ± 8.0 0.934 −5.7 0.025*
Changes at follow-up SBP −5.0 ± 11.7 0.135 2.3 ± 10.8 0.525 −8.6 0.031*
DBP −4.6 ± 4.6 0.002** 3.3 ± 8.0 0.139 −7.8 0.004**
a Values are the mean ± SD (mmHg).
b Differences between groups; values are the difference (mmHg) by least squares method.
c P-value within group by paired t-test or Wilcoxon signed-rank test.
d P-value between groups by analysis of covariance adjustment.
* P < 0.05.
** P < 0.01.



















aFig. 3. Blood pressure during the study period.
ecrease in SBP (−7.1 mmHg; P = 0.027) and in DBP (−7.5 mmHg;
 = 0.001). In the control group, neither DBP nor SBP were signiﬁ-
antly changed (Table 2).
. Heart rate variability
Among the HRV indices (TP, VLF, LF and HF), only HF showed
igniﬁcant differences between groups at week 4 (0.7; 95% CI: 0.0,
.4; P = 0.047) and week 8 (0.7; 95% CI: 0.7, 1.3; P = 0.030).
In the acupuncture group, all the HRV indices changed signif-
cantly at week 8: the change in TP was 0.6 (P = 0.001), in VLF,
.6 (P = 0.024), in LF, 0.4 (P = 0.028), and in HF, 0.5 (P = 0.024). The
RV indices were not signiﬁcantly changed in the control group
Table 3).
. EQ-5D
There were no signiﬁcant differences in EQ-5D scores between
roups at week 4, week 8 or follow-up (P = 0.499, P = 0.246 and
 = 0.839, respectively). There were also no changes within groups
Table 4).
. Lipid proﬁle and BMI
There were no signiﬁcant differences in BMI between groups
t week 4, week 8 or follow-up (P = 0.988, P = 0.917 and P = 0.466,
espectively). Similarly, there were no signiﬁcant differences in
lood lipid proﬁle indices, namely HDL (P = 0.641), LDL (P = 0.356)
nd total cholesterol (P = 0.172) at week 8 (Table 5).8. Sample size
We  calculated the appropriate sample size for a further study
based on the difference of SBP and DBP changes between groups,
with consideration of a 5% signiﬁcant level, two-tailed test, 80%
power, and a t-test for comparison between groups.
Given a minimum effect size of 0.46 in SBP, the sample size
would be 20 participants per group. Considering a 20% dropout rate,
25 participants per group would need to be recruited. Given a min-
imum effect size of 0.90 in DBP, the sample size would be 77 per
group. Considering a 20% dropout rate, 97 participants per group
would need to be recruited.
8.1. Safety
Previous studies of acupuncture on hypertension have reported
that adverse events would be spot bleeding, feeling of pain in the
skin-puncture site, and giddiness, hypertensive urgencies and con-
gestive heart failure.13,17 In this trial, it has not reported any adverse
events.
9. Discussion
Recent meta-analyses have suggested that acupuncture is asso-
ciated with reductions of 7.5 mmHg  and 4.2 mmHg  in SBP and DBP,
respectively. 15 In this study, acupuncture decreased SBP and DBP
by approximately 6.0 and 5.7 mmHg, respectively, suggesting its
potential beneﬁts for patients with prehypertension and stage I
hypertension. There are three important differences between the
present study and studies included in the meta-analyses men-
tioned above. First, studies in the meta-analyses used noninvasive
sham acupuncture, and this study used no-treatment as the con-
trol. Second, the range of blood pressure of included participants
was different. Although previous studies included participants with
hypertension 15 or high stage BP, 16 this study included only pre and
mild hypertension. Third, the frequency and duration of acupunc-
ture treatment were different. These differences might contribute
to a different effect on BP between studies. There was  a 22% reduc-
tion in Coronary Heart Disease events and a 41% reduction in stroke
for a BP reduction of 10 mm  Hg SBP or 5 mm  Hg DBP.26 So, the reduc-
tion of DBP might clinically meaningful based on this study even
though the change of SBP was not signiﬁcant. However, due to small
sample size of this pilot study, clinical impact of this results should
be conﬁrmed in larger trials. Further studies involving rigorously
designed large-scale trials will be required to investigate the effect
of acupuncture on hypertension, particularly on early-stage hyper-
tension. The ﬁndings of such studies could help prevent or delay
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Table  3
Changes in HRV from baseline to week 4, week 8, and follow-up.
Acupuncture (n = 15)a Control (n = 15)a Acupuncture vs. Controlb
Indexa P c Indexa P d Indexb P c
Baseline TP 5.9 ± 0.7 – 6.0 ± 0.7 – – –
VLF  5.1 ± 0.9 – 5.1 ± 0.7 – – –
LF  4.4 ± 0.8 – 4.5 ± 1.2 – – –
HF  4.6 ± 0.8 – 4.5 ± 1.1 – – –
Changes  in week 4 TP 0.3 ± 0.7 0.096 −0.0 ± 0.7 0.927 0.3 0.214
VLF  0.2 ± 0.5 0.305 0.0 ± 1.0 0.850 0.1 0.732
LF  0.4 ± 1.0 0.127 0.0 ± 0.8 0.776 0.3 0.312
HF  0.5 ± 1.0 0.097 −0.2 ± 0.8 0.324 0.7 0.047*
Changes in week 8 TP 0.6 ± 0.6d 0.001*** 0.1 ± 0.9 1.000 0.5 0.072
VLF  0.6 ± 1.0d 0.024* 0.2 ± 1.0 0.522 0.4 0.185
LF  0.4 ± 0.6d 0.028* 0.2 ± 1.2 0.893 0.2 0.623
HF  0.5 ± 0.8d 0.024* −0.1 ± 0.9 0.542 0.7 0.030*
Changes at follow-up TP 0.6 ± 1.2 0.111 0.2 ± 1.0 0.400 0.2 0.523
VLF  0.6 ± 1.3 0.093 0.2 ± 1.1 0.456 0.3 0.417
LF  0.4 ± 1.0 0.163 0.3 ± 0.9 0.215 0.0 0.897
HF  0.4 ± 1.4 0.519 0.2 ± 0.9 0.839 0.2 0.642
**P < 0.01.
a Values are the mean ± SD.
b Differences between groups; values are the differences by least squares method.
c P-value between groups was analyzed by analysis of covariance adjustment.
d Changes within group; P < 0.05.
* P < 0.05.
*** P < 0.001.
Table 4
Changes in EQ-5D at week 4, week 8, and follow-up.
Acupuncture (n = 15)a Control (n = 15)a Acupuncture vs. controlb Pc
Baseline 0.93 ± 0.09 0.97 ± 0.06 – –
Changes in week 4 0.91 ± 0.12 0.96 ± 0.06 −0.02 0.499
Changes in week 8 0.95 ± 0.08 0.94 ± 0.13 0.04 0.246
Changes at follow-up 0.90 ± 0.13 0.95 ± 0.07 −0.01 0.839
a Values are the mean ± SD.
b Values are the differences between groups with by least squares method.
c P-value between groups was analyzed by analysis of covariance adjustment.
Table 5
Changes in BMI  and blood lipid proﬁle at week 4, week 8, and follow-up.
Acupuncture(n = 15)a Control(n = 15)a Acupuncture vs. controlb Pc
Baseline BMI, kg/m2 23.5 ± 3.1 24.5 ± 3.4 – –
Change  in week 4 23.5 ± 3.1 24.5 ± 3.4 0.00 0.988
Change  in week 8 BMI  23.5 ± 3.0 24.4 ± 3.4 −0.11
Change at follow-up BMI  23.6 ± 3.0 24.6 ± 3.4 −0.08
Baseline Blood lipid proﬁle, mg/dl
HDL 50.5 ± 10.8 50.2 ± 12.8 – –
LDL  125.6 ± 16.9 105.9 ± 19.1 – –
Total  cholesterol 198.5 ± 20.9 183.7 ± 27.7 – –
Change  in week 8 HDL 51.7 ± 9.9 52.3 ± 12.4 −0.90 0.641
LDL  124.3 ± 21.8 114.9 ± 27.8 −7.78 0.356












aa Values are the mean ± SD.
b Values are the difference CI by least squares method.
c P-value between groups was analyzed by analysis of covariance adjustment.
rogression to hypertension, and ultimately reduce cardiovascular
isk and cardiac mortality.
Choosing an appropriate duration and frequency for acupunc-
ure treatment is an issue.27 A study claimed that short-term (5
ays) acupuncture does not signiﬁcantly decrease BP.28 Indeed, the
uration and frequency of effective acupuncture for hypertension
anges from 6 to 8 weeks, 2 or 5 times a week.13 In the present study,
e found a signiﬁcant reduction of DBP after 8 weeks of acupunc-
ure treatment compared to control (P = 0.025), and a signiﬁcant
eduction of SBP and DBP after only 4 weeks (P = 0.027 and P = 0.007,
espectively). Based on this and previous studies, the duration and
requency of acupuncture for hypertension should be four weeks
t least, two times or more per week.Deregulation of the autonomic nervous system plays an impor-
tant role in BP regulation.29,30 The autonomic function can be
measured by means of the HRV.31 It has been reported that
hypertensive patients have low HRV.29,32 Therefore, HRV indices
have been used to investigate the effects of anti-hypertensive
therapies.33,34 In this study, HF was signiﬁcantly increased in the
acupuncture group compared to control at week 8, which indicates
an increase in parasympathetic activity in the acupuncture group.
Additionally, all HRV indices showed signiﬁcant improvement in
the acupuncture group at week 8, although this improvement was
too small to lead to differences between groups. Some review stud-
ies have provided evidence of the beneﬁts of acupuncture to the
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cupuncture on HRV of patients with high BP. Therefore, further
esearch is required to use objective and clinically relevant out-
omes such as HRV in combination with BP to understand the
echanism of acupuncture-induced lowering of BP.
In this study, there were no signiﬁcant improvements in qual-
ty of life (Table 4). There might be two reasons. Firstly, baseline
Q-5D scores were high (Table 1; 0.93 in the acupuncture group
nd 0.97 in the control group). According to Korea Health Statistics
012, the average score of EQ-5D in the healthy population is 0.96,
nd 0.91 in the hypertensive population.2 Secondly, EQ-5D might
ot be appropriate to evaluate patients with prehypertension and
tage I hypertension. In previous hypertension, general quality of
ife instruments such as the MOSSF-36 or EQ-5D were used to assess
he health status.37,38 However, there is no validated hypertension-
peciﬁc instrument yet. It would be important to develop such an
nstrument.
At week 4, both SBP and DBP differed signiﬁcantly between
roups; however, at week 8, only DBP, but not SBP, was signiﬁcantly
ifferent (Table 2, Fig. 3). Three factors, considered limitations
f this study, might have inﬂuenced the results. Firstly, blinding
f participants was not possible due to the non-treated control
esign of the study, so the effect of expectation and Howthorn
ffect might affect the participants in acupuncture group. In addi-
ion, even though we had trained researchers and acupuncturists
ot to over-communicate to participants in the treatment group,
he interaction between researchers and participants might affect
he result.39 Secondly, change of researchers might affected the
esult. Due to the strict inclusion and exclusion criteria (untreated
rehypertension and stage I hypertension), this trial took us 13
onths to complete; inevitable situations such as the change in
esearch coordinator occurred, that such changes might inﬂuence
he interaction between participants and researchers even though
e let them follow the SOP on interaction. Finally, the adherence
f participants might not be consistent over the course of the trial.
any factors affect participant adherence, e.g., the inability of the
articipants to completely understand their responsibilities, the
esearcher’s unfamiliarity with the protocol, and the long duration
f trial.40 In this study, although all the participants were asked
o maintain their usual life style and to not use any type of anti-
ypertensive treatment including diet or exercise, whether they
omplied with the request was not monitored suitably, and thus
emains unclear. Further research is need to develop a self-report
orm that can be used to measure the adherence of participants. In
ddition, practitioners and research coordinators should be given
 manual regarding revised or standard operating procedures, in
rder to prevent unnecessary bias.
0. Conclusion
The results of this study show that acupuncture might lower BP
n patients with prehypertension and stage I hypertension, and fur-
her large-scale studies need 97 participants per group. The effect
f acupuncture on prehypertension and mild hypertension should
e conﬁrmed in larger studies.
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